HN2001000118A - Un estuche de combinacion usado en el tratamiento de paludismo. - Google Patents

Un estuche de combinacion usado en el tratamiento de paludismo.

Info

Publication number
HN2001000118A
HN2001000118A HN2001000118A HN2001000118A HN2001000118A HN 2001000118 A HN2001000118 A HN 2001000118A HN 2001000118 A HN2001000118 A HN 2001000118A HN 2001000118 A HN2001000118 A HN 2001000118A HN 2001000118 A HN2001000118 A HN 2001000118A
Authority
HN
Honduras
Prior art keywords
treatment
amino
days
paludism
combination case
Prior art date
Application number
HN2001000118A
Other languages
English (en)
Inventor
Joseph Francis Pinto
Ajay Swati Piramal
Ram Pratap
Prasad Amiya Bhaduri
Pati Harsh Thapliyal
Kumar Sunil Puri
Prasad Guru Dutta
Kumar Anil Dwivedi
Satyawan Singh
Pratima Srivastava
Chandra Vikash Pandey
Sudhir Srivastava
Original Assignee
Nicholas Piramal India Ltd Soc De La India
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd Soc De La India filed Critical Nicholas Piramal India Ltd Soc De La India
Publication of HN2001000118A publication Critical patent/HN2001000118A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

UN ESTUCHE DE COMBINACION PARA EL TRTAMIENTO DEL PALUDISMO PRODUCIDO POR PLASMODIUM VIVAX (P.VIVAX), QUE TIENE DOSIS INDIVIDUALES DE UN AGENTE ANTIPALUDICO, 3-[1-[[4-[(6-METOXI-8-QUINOLINIL)AMINO]PENTIL]AMINO]ETILIDENO]-DIHIDRO-2-(3H) FURANONA (I) EN FORMA DE CAPSULAS; DOSIS INDIVIDUALES DEL AGENTE, ANTIPALUDICO CLOROQUINAEN FORMA DE COMPRIMIDOS; Y MATERIAL DE INSTRUCCIONES PARA LA ADMINISTRACION DE LOS FARMACOS ANTIPALUDICOS. EL ESTUCHE DE COMBINACION ES PARTICULARMENTEADECUADO PARA UN REGIMEN DE TRATAMIENTO DE 6 DIAS, EN EL QUE EL TRATAMIENTO SE CONSIGUE MEDIANTE CINCO COMPRIMIDOS QUE CONTIENEN 500mg. DE FOSFATO DE CLOROQUINA (EQUIVALENTES A 300 mg. DE BASE), DEBIENDO TOMARSE TRES EL DIA UNO Y UNO CADA UNO DE LOS DIAS DOS Y TRESE; Y CINCO CAPSULAS QUE CONTIENE 25 mg. DE 3-[1-[ [4-[(6- METOXI-8-QUILONIL) AMINO]PENTIL] AMINO] ETILIDENO] DIHIDRO-2--(3H) FURANONA (I), DEBIENDO TOMARSE UNA CADA UNO DE LOS DIAS DOS A SEIS.
HN2001000118A 2000-05-31 2001-05-30 Un estuche de combinacion usado en el tratamiento de paludismo. HN2001000118A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31

Publications (1)

Publication Number Publication Date
HN2001000118A true HN2001000118A (es) 2001-10-29

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000118A HN2001000118A (es) 2000-05-31 2001-05-30 Un estuche de combinacion usado en el tratamiento de paludismo.

Country Status (28)

Country Link
US (1) US7404962B1 (es)
EP (1) EP1292306B1 (es)
JP (1) JP2004505017A (es)
KR (1) KR20030025926A (es)
AP (1) AP1435A (es)
AR (1) AR028458A1 (es)
AT (1) ATE314848T1 (es)
AU (2) AU2001228790B2 (es)
BR (1) BR0005247A (es)
CA (1) CA2413775C (es)
CR (1) CR6835A (es)
CZ (1) CZ296875B6 (es)
DE (2) DE00993875T1 (es)
DK (1) DK1292306T3 (es)
EC (1) ECSP003694A (es)
ES (1) ES2200729T3 (es)
GT (1) GT200000187A (es)
HK (1) HK1052467B (es)
HN (1) HN2001000118A (es)
HU (1) HUP0301925A3 (es)
MX (1) MXPA02011883A (es)
NO (1) NO324774B1 (es)
OA (1) OA12276A (es)
PE (1) PE20011319A1 (es)
PL (1) PL200748B1 (es)
SV (1) SV2002000201A (es)
WO (1) WO2001091535A2 (es)
ZA (1) ZA200209726B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114892B2 (en) * 2006-02-16 2012-02-14 The Mclean Hospital Corporation Methods and compositions for the treatment of Parkinson's Disease
WO2010065932A1 (en) * 2008-12-05 2010-06-10 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
JP3560970B2 (ja) * 1992-02-07 2004-09-02 ノバルティス アクチェンゲゼルシャフト ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物

Also Published As

Publication number Publication date
AU2879001A (en) 2001-12-11
WO2001091535A3 (en) 2002-07-04
AU2001228790B2 (en) 2007-02-01
AP2002002672A0 (en) 2002-12-31
PE20011319A1 (es) 2002-03-02
HUP0301925A3 (en) 2009-03-30
ES2200729T1 (es) 2004-03-16
MXPA02011883A (es) 2004-05-17
HK1052467A1 (en) 2003-09-19
JP2004505017A (ja) 2004-02-19
HUP0301925A2 (hu) 2003-09-29
DE60025403D1 (de) 2006-03-30
DK1292306T3 (da) 2006-05-22
NO324774B1 (no) 2007-12-10
NO20025765D0 (no) 2002-11-29
WO2001091535B1 (en) 2002-10-31
DE00993875T1 (de) 2004-04-15
AR028458A1 (es) 2003-05-07
AP1435A (en) 2005-06-21
PL200748B1 (pl) 2009-02-27
EP1292306B1 (en) 2006-01-04
ES2200729T3 (es) 2006-07-16
ZA200209726B (en) 2004-03-10
HK1052467B (zh) 2006-03-10
CA2413775C (en) 2009-08-25
GT200000187A (es) 2002-04-18
DE60025403T2 (de) 2006-08-24
SV2002000201A (es) 2002-10-24
NO20025765L (no) 2003-01-08
PL372718A1 (en) 2005-07-25
BR0005247A (pt) 2002-02-13
WO2001091535A2 (en) 2001-12-06
CZ20024071A3 (cs) 2003-04-16
CR6835A (es) 2007-04-26
OA12276A (en) 2006-05-10
KR20030025926A (ko) 2003-03-29
US7404962B1 (en) 2008-07-29
ATE314848T1 (de) 2006-02-15
EP1292306A2 (en) 2003-03-19
ECSP003694A (es) 2002-01-25
CA2413775A1 (en) 2001-12-06
CZ296875B6 (cs) 2006-07-12

Similar Documents

Publication Publication Date Title
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
AR025962A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que los contienen
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
ES2090368T3 (es) Composiciones farmaceuticas que contienen glucosaminoglicanos absorbibles por via oral.
NO20053142L (no) Allergen doseringsform.
SE8304393D0 (sv) Controlled release naproxen and naproxen sodium tablets
FI944035A (fi) Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen
UY26439A1 (es) Nueva composición y uso
ES2157881T3 (es) Metanosulfonato de paroxetina.
EA200401317A1 (ru) Композиции и способы дозирования липосом определенных размеров для лечения или предотвращения заболевания
CO5540373A2 (es) Composicion farmaceutica de liberacion sostenida
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
CO5200840A1 (es) Combinacion de sustancias activas con clonidina
ECSP078014A (es) Regimen de dosificacion para prasugrel
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
CO4920200A1 (es) Empaques farmaceuticos para ayudar o aumentar el cumplimien- to en la administracion de un regimen complejo de droga por via oral y metodos para su utilizacion
HN2001000118A (es) Un estuche de combinacion usado en el tratamiento de paludismo.
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
CO5271706A1 (es) Unidad de dosis de mirtazapina para el tratamiento de transtornos del sueno
HN2001000038A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion